Differing mechanisms of cAMP- versus seawater-induced oocyte maturation in marine nemertean worms II. The roles of tyrosine kinases and phosphatases
Instead of blocking oocyte maturation as it does in most animals, cAMP causes oocytes of marine nemertean worms to initiate maturation (=germinal vesicle breakdown, “GVBD”). To characterize cAMP‐induced GVBD in nemerteans, inhibitors of tyrosine kinase signaling were tested on Cerebratulus sp. oocyt...
Gespeichert in:
Veröffentlicht in: | Molecular reproduction and development 2006-12, Vol.73 (12), p.1564-1577 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Instead of blocking oocyte maturation as it does in most animals, cAMP causes oocytes of marine nemertean worms to initiate maturation (=germinal vesicle breakdown, “GVBD”). To characterize cAMP‐induced GVBD in nemerteans, inhibitors of tyrosine kinase signaling were tested on Cerebratulus sp. oocytes that had been incubated in cAMP‐elevating drugs versus seawater (SW) alone. Such tests yielded similar results for Src‐like tyrosine kinase blockers, as the inhibitors prevented mitogen‐activated protein kinase (MAPK) activation without stopping either GVBD or maturation‐promoting factor (MPF) activation in both SW and cAMP‐elevating treatments. Alternatively, genistein, a general tyrosine kinase antagonist, and piceatannol, an inhibitor of the tyrosine kinase Syk, reduced GVBD and MAPK/MPF activities in SW‐, but not cAMP‐induced maturation. Similarly, inhibitors of the human epidermal growth factor receptor‐2 (HER‐2) tyrosine kinase prevented GVBD and MAPK/MPF activations in oocytes treated with SW, but not with cAMP‐elevating drugs. Antagonists of either protein tyrosine phosphatases (PTPs) or the dual‐specificity phosphatase Cdc25 also reduced GVBD and MAPK/MPF activities in SW‐treated oocytes without generally affecting cAMP‐induced maturation. Collectively, these data suggest cAMP triggers GVBD via pathways that do not require MAPK activation or several components of tyrosine kinase signaling. In addition, such differences in tyrosine kinase cascades, coupled with the dissimilar patterns of Ser/Thr kinase signaling described in the accompanying study, indicate that nemertean oocytes are capable of utilizing multiple mechanisms to activate MPF during GVBD. Mol. Reprod. Dev. 73: 1564–1577, 2006. © 2006 Wiley‐Liss, Inc. |
---|---|
ISSN: | 1040-452X 1098-2795 |
DOI: | 10.1002/mrd.20596 |